HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katherine A Vallis Selected Research

111In-DTPA-human epidermal growth factor

8/2008Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF.
6/2006Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katherine A Vallis Research Topics

Disease

46Neoplasms (Cancer)
01/2022 - 08/2002
30Breast Neoplasms (Breast Cancer)
10/2021 - 02/2002
5Brain Neoplasms (Brain Tumor)
01/2021 - 11/2013
5Neoplasm Metastasis (Metastasis)
11/2020 - 01/2012
3Body Weight (Weight, Body)
07/2010 - 09/2003
2Triple Negative Breast Neoplasms
10/2021 - 01/2020
2Colorectal Neoplasms (Colorectal Cancer)
11/2020 - 01/2019
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2020 - 01/2019
2Lung Neoplasms (Lung Cancer)
03/2020 - 03/2020
2Neuroblastoma
01/2017 - 01/2017
2Carcinogenesis
01/2012 - 07/2011
2Myocardial Infarction
03/2007 - 02/2002
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2021
1Liver Neoplasms (Liver Cancer)
03/2021
1Hepatocellular Carcinoma (Hepatoma)
03/2021
1Inflammation (Inflammations)
01/2021
1Cognitive Dysfunction
01/2021
1Glioblastoma (Glioblastoma Multiforme)
01/2020
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2020
1Prostatic Neoplasms (Prostate Cancer)
02/2019
1Hypoxia (Hypoxemia)
01/2019
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2016

Drug/Important Bio-Agent (IBA)

10Radioisotopes (Radionuclides)IBA
10/2021 - 12/2010
9Epidermal Growth Factor (EGF)IBA
01/2019 - 09/2003
8Peptides (Polypeptides)IBA
01/2020 - 03/2007
7Trastuzumab (Herceptin)FDA Link
11/2013 - 08/2007
6DNA (Deoxyribonucleic Acid)IBA
09/2020 - 03/2009
6RutheniumIBA
09/2020 - 01/2016
6AcidsIBA
01/2017 - 09/2003
5RadiopharmaceuticalsIBA
09/2020 - 09/2003
5Pentetic Acid (DTPA)FDA LinkGeneric
12/2012 - 04/2004
4ErbB Receptors (EGF Receptor)IBA
09/2007 - 09/2003
3Telomerase (Telomerase Reverse Transcriptase)IBA
10/2021 - 01/2017
3Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2012
3LigandsIBA
02/2019 - 10/2016
3Pharmaceutical PreparationsIBA
01/2019 - 01/2015
3Intercalating AgentsIBA
01/2018 - 01/2016
3Methotrexate (Mexate)FDA LinkGeneric
03/2010 - 08/2002
2Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2004
2Cell-Penetrating PeptidesIBA
01/2022 - 03/2014
2AntibodiesIBA
01/2022 - 11/2013
2Estrogen ReceptorsIBA
10/2021 - 09/2003
2SirtuinsIBA
03/2021 - 11/2020
2GoldIBA
01/2020 - 11/2016
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2020 - 01/2018
2Biological ProductsIBA
01/2019 - 01/2015
2PhenanthrolinesIBA
01/2018 - 01/2016
2NucleolinIBA
10/2016 - 02/2012
21,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2016 - 03/2009
2EpitopesIBA
11/2013 - 03/2007
2Immunoconjugates (Immunoconjugate)IBA
11/2012 - 03/2007
2Bleomycin (Blenoxane)FDA LinkGeneric
11/2012 - 07/2011
2Saline SolutionIBA
07/2010 - 09/2003
2Alanine Transaminase (SGPT)IBA
07/2010 - 09/2003
2CreatinineIBA
07/2010 - 09/2003
2Hemoglobins (Hemoglobin)IBA
07/2010 - 09/2003
2111In-DTPA-human epidermal growth factorIBA
08/2008 - 06/2006
1NucleotidesIBA
10/2021
1Glucose (Dextrose)FDA LinkGeneric
10/2021
1Lactic Acid (Lactate)FDA LinkGeneric
10/2021
1Progesterone Receptors (Progesterone Receptor)IBA
10/2021
1Yttrium-90IBA
03/2021
14,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
12/2020
1Maytansine (Maitansine)IBA
12/2020
1ProdrugsIBA
12/2020
1A-Form DNA (A-DNA)IBA
09/2020
1Protons (Proton)IBA
03/2020
1lutetium Lu 177 dotatateIBA
01/2020
1Octreotide (Sandostatin)FDA LinkGeneric
01/2020
1olaparibIBA
01/2020
1Somatostatin Receptors (Somatostatin Receptor)IBA
01/2020
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2020
1salicylhydroxamic acid (SHAM)IBA
01/2020
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2020
1MetalsIBA
01/2019
1Liposomes (Liposome)IBA
01/2019
1OligonucleotidesIBA
01/2019
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1NVP-BKM120IBA
01/2019
1Therapeutic UsesIBA
06/2018
1Cisplatin (Platino)FDA LinkGeneric
01/2018
1Coloring Agents (Dyes)IBA
07/2017
1Molecular Probes (Molecular Probe)IBA
07/2017
1Radium-223IBA
01/2017
1Histones (Histone)IBA
01/2016
1Type I Tumor Necrosis Factor ReceptorsIBA
11/2013
1GadoliniumIBA
11/2013
1Lymphotoxin-alpha (Lymphotoxin)IBA
11/2013
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
11/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2013

Therapy/Procedure

20Therapeutics
10/2021 - 02/2002
17Radiotherapy
10/2021 - 02/2002
3Drug Therapy (Chemotherapy)
11/2020 - 08/2002
3Precision Medicine
09/2020 - 01/2018
3Segmental Mastectomy (Lumpectomy)
07/2015 - 02/2002
2Radioimmunotherapy
01/2021 - 09/2008
2Proton Therapy
03/2020 - 03/2020
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
03/2020
1Microbubbles
01/2019